Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

TOVX — Theriva Biologics, Inc. Dilution Risk Tracker

Track TOVX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TOVX — Get alerts when the score changes →

As of October 13, 2026, Theriva Biologics, Inc. (TOVX) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Theriva Biologics, Inc. has a market capitalization of $10.21M, 45.89M shares outstanding, 10 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 37%
🔄 Reverse Split model est. 65%
• 50-day avg $0.29 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track TOVX — Get forecast alerts →

Market Data

Market Cap$10.21M
Shares Outstanding45.89M
Float45.14M
Cash$14.20M
Debt$1.73M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding45.89MVerified float table or market cache
Public Float45.14MVerified float table or market cache
Market Cap$10.21MMarket data cache
Cash Runway9.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 8-K 3, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 1.17M shares
#1 Vanguard Group Inc 255.7K shares
#2 Geode Capital Management, LLC 212.1K shares
#3 Morgan Stanley 200.0K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.71M
Days to Cover3.9
% of Float3.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-12
xbrl XBRL CONVERTIBLE 2025-08-11
8-K 8K EVENT 2026-06-05
8-K 8K EVENT 2026-04-09
8-K 8K EVENT 2026-02-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TOVX Dilution Snapshot

Theriva Biologics, Inc. (TOVX) has a DilutionScore of 56/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TOVX's DilutionScore is currently 56/100 (High risk), with 4 score changes tracked over 89 days. The score deteriorated from 68/100 (High risk).

Period Score Risk Level Duration
Oct 11 – Oct 13, 202656/100HIGH3 days
Oct 01 – Oct 10, 202668/100HIGH10 days
Aug 22 – Sep 30, 202674/100HIGH40 days
Aug 14 – Aug 21, 202677/100CRITICAL7 days
Jul 16 – Aug 13, 202674/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TOVX shares outstanding have decreased 0.0% from 35.69M (Mar 2026) to 35.69M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 14, 202635.69M33.19M▼ 5.46%
Mar 09, 202635.69M33.19M▲ 0.48%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TOVX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TOVX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TOVX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TOVX
TOVX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.